# FDA Inspection 1262087 - OneBlood, Inc - February 20, 2025

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/00af161e-3ffb-4c98-9453-1d4aaa28b6fd
Source feed: FDA_Inspections

> FDA Inspection 1262087 for OneBlood, Inc on February 20, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262087
- Company Name: OneBlood, Inc
- Inspection Date: 2025-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262087 - 2025-02-20](https://www.keypedia.com/records/fda_inspections/oneblood-inc/edba3ba4-9019-47b4-ad67-5b5c9853f395)
- [FDA Inspection 1152583 - 2021-09-01](https://www.keypedia.com/records/fda_inspections/oneblood-inc/570e20bf-438e-41d3-843f-1742beed61a6)
- [FDA Inspection 1051870 - 2018-03-20](https://www.keypedia.com/records/fda_inspections/oneblood-inc/b2c6c0b9-a4c5-49f4-b7e8-9d15d21b9bce)
- [FDA Inspection 972178 - 2016-05-02](https://www.keypedia.com/records/fda_inspections/oneblood-inc/2dfea1be-c1f0-4eae-9d8e-434d744a0087)
- [FDA Inspection 883106 - 2014-06-13](https://www.keypedia.com/records/fda_inspections/oneblood-inc/3eceb9ab-6109-4a28-b6e4-8b0eb448b679)

Company: https://www.keypedia.com/companies/oneblood-inc/27740982-831b-4526-9d83-5ed80e408b23

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d